A 25-year review of advances in testicular cancer: Perspectives on evaluation, treatment, and future directions/challenges
- 1 September 2021
- journal article
- review article
- Published by Elsevier in Urologic Oncology: Seminars and Original Investigations
- Vol. 39 (9) , 561-568
Abstract
No abstract availableKeywords
This publication has 65 references indexed in Scilit:
- 2-18fluoro-deoxy-D-glucose positron emission tomography (FDG-PET) for postchemotherapy seminoma residual lesions: a retrospective validation of the SEMPET trialAnnals of Oncology, 2011
- Randomized Trials in 2466 Patients With Stage I Seminoma: Patterns of Relapse and Follow-upJNCI: Journal of the National Cancer Institute, 2011
- Cardiovascular Risk Factors and Morbidity in Long-Term Survivors of Testicular Cancer: A 20-Year Follow-Up StudyJournal of Clinical Oncology, 2010
- A phase 1 and pharmacodynamic study of decitabine in combination with carboplatin in patients with recurrent, platinum‐resistant, epithelial ovarian cancerCancer, 2010
- Long‐term neurologic and peripheral vascular toxicity after chemotherapy treatment of testicular cancerCancer, 2010
- Long-Term Follow-Up of Cisplatin Combination Chemotherapy in Patients With Disseminated Nonseminomatous Germ Cell Tumors: Is a Postchemotherapy Retroperitoneal Lymph Node Dissection Needed After Complete Remission?Journal of Clinical Oncology, 2010
- Observational Study of Prevalence of Long-term Raynaud-Like Phenomena and Neurological Side Effects in Testicular Cancer SurvivorsJNCI: Journal of the National Cancer Institute, 2009
- Phase II trial of sunitinib in patients with relapsed or refractory germ cell tumorsInvestigational New Drugs, 2009
- Predicting Teratoma in the Retroperitoneum in Men Undergoing Post-Chemotherapy Retroperitoneal Lymph Node DissectionJournal of Urology, 2006
- Long-Term Risk of Cardiovascular Disease in 5-Year Survivors of Testicular CancerJournal of Clinical Oncology, 2006